MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MXCT MaxCyte Inc

已收盘 11-22 16:00:00 EST

3.55

+0.10

+2.90%

盘后3.55

+0.000.00%

16:10 EST

最高3.63	最低3.39	成交量51.70万
今开3.45	昨收3.45	日振幅7.10%
总市值3.74亿	流通市值3.41亿	总股本1.05亿
成交额182.35万	换手率0.54%	流通股本9,594万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MXCT","market":"US","secType":"STK","nameCN":"MaxCyte Inc","latestPrice":3.55,"timestamp":1732309200000,"preClose":3.45,"halted":0,"volume":516969,"hourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.55,"latestTime":"16:10 EST","volume":4889,"amount":17355.84,"timestamp":1732309839697},"delay":0,"floatShares":95942293,"shares":105482558,"eps":-0.342338,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1,"latestTime":"11-22 16:00:00 EST","open":3.45,"high":3.63,"low":3.385,"amount":1823460.914729,"amplitude":0.071014,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.342338,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1627617600000,"adjPreClose":3.45,"preHourTrading":{"tag":"盘前","latestPrice":3.45,"preClose":3.45,"latestTime":"09:12 EST","volume":1,"amount":3.45,"timestamp":1732284737632},"postHourTrading":{"tag":"盘后","latestPrice":3.55,"preClose":3.55,"latestTime":"16:10 EST","volume":4889,"amount":17355.84,"timestamp":1732309839697},"volumeRatio":0.796813,"impliedVol":0.0565,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/MXCT/wiki","defaultTab":"wiki","newsList":[{"id":"2485121354","title":"Maxcyte, Inc.盘中异动 下午盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485121354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485121354?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:18","pubTimestamp":1732303106,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时18分，Maxcyte, Inc.股票出现异动，股价大幅上涨5.07%。截至发稿，该股报3.63美元/股，成交量28.3651万股，换手率0.27%，振幅6.81%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.14%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123031826971a8299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123031826971a8299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2485217365","title":"Maxcyte, Inc.盘中异动 临近收盘快速拉升5.10%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485217365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485217365?lang=zh_cn&edition=full","pubTime":"2024-11-21 04:58","pubTimestamp":1732136286,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日04时58分，Maxcyte, Inc.股票出现异动，股价大幅上涨5.10%。截至发稿，该股报3.50美元/股，成交量35.9564万股，换手率0.34%，振幅6.16%。机构评级方面，在所有8家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.14%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121045807a249665e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121045807a249665e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2484041606","title":"Maxcyte, Inc.盘中异动 下午盘急速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484041606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484041606?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:12","pubTimestamp":1731953571,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时12分，Maxcyte, Inc.股票出现异动，股价快速跳水5.12%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为1.05%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021251abcd0ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021251abcd0ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","MXCT"],"gpt_icon":0},{"id":"2483330679","title":"Maxcyte, Inc.2024财年第三财季实现净利润-11.56百万美元，同比减少2.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483330679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483330679?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686425,"startTime":"0","endTime":"0","summary":"11月16日，Maxcyte, Inc.公布财报，公告显示公司2024财年第三财季净利润为-11.56百万美元，同比减少2.76%；其中营业收入为8.16百万美元，同比增加2.00%，每股基本收益为-0.11美元。从资产负债表来看，Maxcyte, Inc.总负债35.31百万美元，其中短期债务907000.00美元，资产负债比为0.08，流动比率为0.10。机构评级：截至2024年11月16日，当前有6家机构对Maxcyte, Inc.目标价做出预测，其中目标均价为8.91美元，其中最低目标价为6.50美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000129abc513ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000129abc513ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT"],"gpt_icon":0},{"id":"2482276309","title":"Maxcyte, Inc.盘中异动 股价大涨5.02%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482276309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482276309?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:47","pubTimestamp":1731358063,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时47分，Maxcyte, Inc.股票出现波动，股价急速上涨5.02%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.63%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204474398e41e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204474398e41e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2481129189","title":"Maxcyte, Inc.盘中异动 急速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481129189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481129189?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:44","pubTimestamp":1730990686,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时44分，Maxcyte, Inc.股票出现波动，股价急速下挫5.15%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.45%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107224446971a5160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107224446971a5160&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2481985606","title":"Maxcyte, Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985606?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903501,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Maxcyte, Inc.股票出现波动，股价大幅上涨5.44%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为1.59%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622314198e40d84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622314198e40d84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2481578505","title":"MaxCyte Inc   预计每股亏损12美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481578505","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481578505?lang=zh_cn&edition=full","pubTime":"2024-11-05 05:18","pubTimestamp":1730755092,"startTime":"0","endTime":"0","summary":"   * MaxCyte Inc    将于11月6日公布截至2024年9月30日的财报，预计季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于马里兰州罗克维尔的公司的营收将从去年同期的800万美元下降7.9%，至737.4万美元。* LSEG分析师对MaxCyte公司的平均预期是每股亏损12美分。* 华尔街对 MaxCyte Inc 的 12 个月目标价中位数为 9.50 美元，高于其 3.77 美元的最新收盘价。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MaxCyte Inc   预计每股亏损12美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MXCT"],"gpt_icon":0},{"id":"2480838310","title":"Maxcyte, Inc.盘中异动 股价大涨5.03%报3.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480838310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480838310?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:00","pubTimestamp":1730473233,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时00分，Maxcyte, Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报3.76美元/股，成交量9.4893万股，换手率0.09%，振幅3.91%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为1.84%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101230033ab9333c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101230033ab9333c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"gpt_icon":0},{"id":"2478232966","title":"Maxcyte, Inc.盘中异动 临近收盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478232966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478232966?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:51","pubTimestamp":1729885876,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时51分，Maxcyte, Inc.股票出现波动，股价急速下跌5.00%。截至发稿，该股报3.61美元/股，成交量25.1906万股，换手率0.24%，振幅5.66%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为1.23%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035116971a2643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026035116971a2643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2474427983","title":"Maxcyte, Inc.盘中异动 大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474427983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474427983?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:48","pubTimestamp":1728492528,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时48分，Maxcyte, Inc.股票出现异动，股价大幅下跌5.03%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.38%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101000484898e3b82f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101000484898e3b82f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2472823515","title":"Maxcyte, Inc.盘中异动 临近收盘快速跳水5.01%报3.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472823515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472823515?lang=zh_cn&edition=full","pubTime":"2024-10-02 03:57","pubTimestamp":1727812664,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日03时57分，Maxcyte, Inc.股票出现波动，股价大幅下挫5.01%。截至发稿，该股报3.70美元/股，成交量26.2536万股，换手率0.25%，振幅4.76%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.56%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203574498e3a08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203574498e3a08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0},{"id":"2468609621","title":"Maxcyte, Inc.盘中异动 早盘急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468609621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468609621?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:15","pubTimestamp":1726841739,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时15分，Maxcyte, Inc.股票出现异动，股价急速跳水5.06%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.38%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092022153998e3844f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092022153998e3844f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2468850808","title":"Maxcyte, Inc.盘中异动 大幅上涨5.17%报4.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468850808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468850808?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:12","pubTimestamp":1726755125,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时12分，Maxcyte, Inc.股票出现异动，股价大幅上涨5.17%。截至发稿，该股报4.27美元/股，成交量6.3026万股，换手率0.06%，振幅3.45%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.81%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221205a1db337b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221205a1db337b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2460344960","title":"Maxcyte, Inc.盘中异动 急速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460344960","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460344960?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074264,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Maxcyte, Inc.股票出现波动，股价急速下挫5.56%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.06%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213104971991dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819213104971991dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"gpt_icon":0},{"id":"2459547193","title":"Maxcyte, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459547193","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459547193?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:08","pubTimestamp":1723734493,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时08分，Maxcyte, Inc.股票出现异动，股价大幅拉升5.06%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.79%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230814ab5ddbd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230814ab5ddbd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4121","MXCT"],"gpt_icon":0},{"id":"2459893301","title":"Maxcyte, Inc.2024财年第二财季实现净利润-9.38百万美元，同比增加10.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459893301","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459893301?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:19","pubTimestamp":1723479547,"startTime":"0","endTime":"0","summary":"8月13日，Maxcyte, Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.38百万美元，同比增加10.75%；其中营业收入为10.43百万美元，同比增加15.38%，每股基本收益为-0.09美元。从资产负债表来看，Maxcyte, Inc.总负债30.24百万美元，其中短期债务878000.00美元，资产负债比为0.09，流动比率为0.15。机构评级：截至2024年8月13日，当前有6家机构对Maxcyte, Inc.目标价做出预测，其中目标均价为8.49美元，其中最低目标价为4.20美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130019199f24e30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130019199f24e30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT"],"gpt_icon":0},{"id":"2458767985","title":"Maxcyte, Inc.盘中异动 早盘大幅拉升5.50%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458767985","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458767985?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469467,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Maxcyte, Inc.股票出现波动，股价急速拉升5.50%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.09%。其相关个股中，Ainos, Inc.、Envoy Medical, Inc.、Venus Concept Inc.涨幅较大，Ainos, Inc.、Aethlon Medical, Inc.、Xylo Technologies Ltd较为活跃，换手率分别为149.82%、5.71%、0.96%，振幅较大的相关个股有Vivos Therapeutics, Inc.、Allurion Technologies, Inc.、Maxcyte, Inc.，振幅分别为8.57%、6.82%、5.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221310796825b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221310796825b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MXCT","BK4121","BK4539"],"gpt_icon":0},{"id":"2457842844","title":"Maxcyte, Inc.盘中异动 早盘股价大跌6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457842844","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457842844?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:49","pubTimestamp":1723038596,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时49分，Maxcyte, Inc.股票出现异动，股价急速跳水6.27%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.06%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807214957aefdbacc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807214957aefdbacc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MXCT","BK4121"],"gpt_icon":0},{"id":"2457886661","title":"MaxCyte公司：我们有信心实现全年指导目标。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457886661","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457886661?lang=zh_cn&edition=full","pubTime":"2024-08-07 14:12","pubTimestamp":1723011157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MXCT","BK4539","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maxcyte.com","stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":-0.1016},{"period":"3month","weight":-0.2069},{"period":"6month","weight":-0.2401},{"period":"1year","weight":-0.2333},{"period":"ytd","weight":-0.266}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。他们是一家领先的商业细胞工程公司，专注于提供支持平台技术，以推进基于细胞的创新研究以及下一代细胞治疗的发现、开发和商业化。在过去的二十年里，他们开发了他们专有的Flow Electroporation平台并将其商业化，该平台促进了各种细胞的复杂工程。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.071156},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.08049},{"month":3,"riseRate":0.666667,"avgChangeRate":0.001829},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.11033},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.039237},{"month":6,"riseRate":0.666667,"avgChangeRate":0.008677},{"month":7,"riseRate":0.666667,"avgChangeRate":0.116855},{"month":8,"riseRate":0,"avgChangeRate":-0.105888},{"month":9,"riseRate":0.25,"avgChangeRate":-0.050539},{"month":10,"riseRate":0.25,"avgChangeRate":-0.03645},{"month":11,"riseRate":0.25,"avgChangeRate":0.080481},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.025988}],"exchange":"NASDAQ","name":"MaxCyte Inc","nameEN":"MaxCyte Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MaxCyte Inc,MXCT,MaxCyte Inc股票,MaxCyte Inc股票老虎,MaxCyte Inc股票老虎国际,MaxCyte Inc行情,MaxCyte Inc股票行情,MaxCyte Inc股价,MaxCyte Inc股市,MaxCyte Inc股票价格,MaxCyte Inc股票交易,MaxCyte Inc股票购买,MaxCyte Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}